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Abstract Micronutrients inﬂuence multiple metabolic
pathways including oxidative and inﬂammatory processes.
Optimum micronutrient supply is important for the main-
tenance of homeostasis in metabolism and, ultimately, for
maintaining good health. With advances in systems biology
and genomics technologies, it is becoming feasible to
assess the activity of single and multiple micronutrients
in their complete biological context. Existing research col-
lects fragments of information, which are not stored
systematically and are thus not optimally disseminated.
The Micronutrient Genomics Project (MGP) was estab-
lished as a community-driven project to facilitate the
development of systematic capture, storage, management,
analyses, and dissemination of data and knowledge gen-
erated by biological studies focused on micronutrient–
genome interactions. Speciﬁcally, the MGP creates a
public portal and open-source bioinformatics toolbox for
all ‘‘omics’’ information and evaluation of micronutrient
and health studies. The core of the project focuses on
access to, and visualization of, genetic/genomic, tran-
scriptomic, proteomic and metabolomic information rela-
ted to micronutrients. For each micronutrient, an expert
The Micronutrient Genomics Project Working Group is a community
effort-based research consortium with a growing number of active
participants,aslistedathttp://www.micronutrientgenomics.org/40661.
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DOI 10.1007/s12263-010-0192-8group is or will be established combining the various
relevant areas (including genetics, nutrition, biochemistry,
and epidemiology). Each expert group will (1) collect all
available knowledge, (2) collaborate with bioinformatics
teams towards constructing the pathways and biological
networks, and (3) publish their ﬁndings on a regular basis.
The project is coordinated in a transparent manner, reg-
ular meetings are organized and dissemination is arranged
through tools, a toolbox web portal, a communications
website and dedicated publications.
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The introduction of genomics in micronutrient research
Micronutrients are essential regulators of important meta-
bolic and physiological processes in humans. Micronutrient
deﬁciencies cause speciﬁc illnesses. Suboptimal intakes
may contribute to the development and severity of chronic
diseases. An increasing number of studies also demon-
strates the undesirability of high micronutrient doses (by
supplements intake for example) in favour of optimal doses
(e.g. [17]). Based on these observations, a continuous
process of re-assessing dietary requirements and upper
safety limits for micronutrients is taking place in the con-
text of public health nutrition [1]. These new reviews are
based on best available science, including considerations
on differential recommendations for subgroups (e.g.,
elderly, children, pregnant women).
With recent advances in systems biology and genomics
technologies, it is becoming feasible to assess the biolog-
ical action of a micronutrient in its complete biological
context, that is, in relation to its effects on multiple met-
abolic pathways, including interactions with other nutrients
in context of genetic make-up. These mechanistic and
integrated (‘systems’) approaches in the micronutrient and
health relationship may complement the pubic health
recommendation approaches and provide reﬁnements in
speciﬁc cases. Three major developments in the area of
genomics now allow us to further study the molecular
mechanisms involved in the (optimal) health relationship
with micronutrients. These are
• the ability to inexpensively analyse genetic variation in
human genes related to micronutrient uptake and
metabolism;
• the unravelling of the molecular complexity of the
modes of action of micronutrients using omics
technologies
• the generation of multiple inter-related biomarkers and
diagnostics that accurately deﬁne optimal micronutrient
intake for health at the molecular level.
The Micronutrient Genomics Project (MGP) described
in this paper is a research community project to stimulate
and facilitate the most recent developments by providing
the required knowledge-based infrastructure for nutritional
recommendations at the genetic subgroup and individual
level. Four observations that necessitate integrating
micronutrient research and genomics are particularly
relevant.
Micronutrients have complex biological actions
The effects of micronutrients depend on a series of phys-
ical, chemical, and physiological processes, including
amount ingested, meal matrix, digestion, absorption, dis-
tribution, metabolism (biotransformation), excretion (last
four collectively known as ADME), genetic factors in all of
the above processes, and last, but not least, cellular
mechanisms of action (e.g., [26, 38]). Each of these pro-
cesses involves a complex interaction among genes, gene
products, and environmental factors. For example, the core
one-carbon pathway that produces S-adenosylmethionine
for methylation and other reactions utilize folate and three
other vitamins (B12, B2, and B6) in conjunction with at
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123least eight enzymes or transporters to perform the core
reactions. Furthermore, metabolites in this pathway are
used in multiple critical cell functions such as DNA syn-
thesis, maintenance methylation of DNA sequences and
neurotransmitter synthesis.
Micronutrients have overlapping biological action
The above example also demonstrates that micronutrients
do not act independently. The need to consider the impact
of micronutrient combinations on biological processes is
becoming increasingly evident, since micronutrients have
overlapping or complementing actions, or even act in
concert (e.g. 5-methyltetrahydrofolate as substrate and
vitamin B12 as cofactor for methionine synthase). Sele-
nium, zinc, folate, vitamins D, E, B2, B6, and B12 are all
involved directly or indirectly in the innate immune
response, oxidative stress response, and DNA metabolism
[25]. Many micronutrients play a role in oxidative stress
defence. From a reductionist viewpoint, it makes sense to
study each pathway and reaction in an isolated manner, as
this provides insight into mechanisms. However, from a
physiological and a systemic (= systems biology) view, the
best approach is to study the role of all actors.
Micronutrients and genetic variations
Until recently, micronutrient research was usually con-
ducted under the assumption that the underlying mecha-
nisms are the same in all humans. About 600 enzymes for
which micronutrients are cofactors are known in the human
proteome, and the genetic diversity of most has not been
extensively characterized. A signiﬁcant effort is now being
made to characterize alleles of ‘‘micronutrient’’ genes
within the human population. A widely studied example is
methylene tetrahydrofolate reductase (MTHFR). The most
studied genetic variants are c.677C[T (p.A222V) and
c.1298A[C (p.E429A). The allele frequency of the
homozygous TT genotype varies from 0% in sub-Saharan
African populations to 25.3% in Colombians [6]. Although
much research focused on these variants, the full range of
human genetic variation in MTHFR and their allele fre-
quencies in various populations have not been studied. For
example, Marini et al. [30] re-sequenced 564 individuals of
diverse genetic ancestry and discovered 14 non-synony-
mous changes including 11 alleles with frequencies \1%
along with the common alleles p.A222V, p.E429A, and
p.R594Q. Increased levels of folate restored MTHFR
activity to the normal range in 4 of the 5 variants and
riboﬂavin, the cofactor of MTHFR, can normalize the
activity of the C677T variant of the enzyme indicating the
feasibility of corrective nutritional intervention for speciﬁc
genotypes [34]. One speciﬁc example is the observation that
riboﬂavin supplementation improves blood pressure spe-
ciﬁcally in cardiovascular disease patients with the MTHFR
677 C[T polymorphism [18]. Other genes involved in
vitamin metabolism also show population differences.
Another example is the p.379A[V (SNP rs7501331) in
the b-carotene 15,150-monoxygenase (BCMO1) gene which
has a high frequency in the individuals of European
ancestry, but much lower frequency in ethnic groups from
China and Japan and is absent in Yoruba Nigerians [26].
This genetic variation is not considered in developing
recommended intakes for vitamin A which were based on
pro-vitamin A conversion factors of either 1:6 or 1:12,
irrespective of the observed large inter-individual variation
in conversion efﬁciency [5, 16, 26, 47]. Variation in genes
involved in metabolism or interactions of micronutrient
genes are likely to generate differing intake requirements
for optimal health in population subgroups and individuals.
Genotype to phenotype translations
The relationships between genetic variation and health
outcomes for almost all micronutrient metabolism genes are
under intense investigation and discussion. Recent exam-
ples are studies on the relationship of vitamin D, selenium,
and carotenoids with cancer [28, 32]. Over 1,600 studies
associating polymorphisms in MTHFR with various disease
or physiological conditions have been published (check
‘‘MTHFR’’ in the Genopedia of http://hugenavigator.net).
In many cases, these studies analyse single micronutrients
and one or several variants in a gene or pathway. A systems
biology approach will add to these studies by integrating
analyses and data from multiple systems and technologies.
The Micronutrient Genomics Project
Although the amount of results from gene–nutrient inter-
action studies is growing rapidly, the available information
is often disconnected and generated by diverse experi-
mental designs that do not allow data comparison or con-
solidation. To fully tap into the potential of data mining,
published data as well as organizing data from research in
the micronutrient genomics ﬁeld, a systematic, searchable,
central repository or portal of genetic and phenotypic
information related to micronutrients are needed. Such a
systematic portal would provide a bioinformatics resource
that can be used to build a global view of micronutrient
biological activity, to drive new studies, and to identify
gene-micronutrient interactions with signiﬁcant effects on
health. A consortium of micronutrient researchers was
formed to create a new set of bioinformatics resources and
to exploit these in research activities and to disseminate
them to the entire micronutrient research community. This
Genes Nutr (2010) 5:285–296 287
123effort is named the Micronutrient Genomics Project
(MGP).
The MGP considers itself an integrative and iterative
project, combining expert knowledge with standard bioin-
formatics resources. It thus explicitly does not replicate but
rather exploits and integrates the invaluable bioinformatics
tools and omics databases that are already available, such
as the Human Variome Project [41], the National Center
for Biotechnology Information (NCBI), The Human Gen-
ome Epidemiology Network (HuGENet) [24], the Euro-
pean Bioinformatics Institute (EBI), and the Human
Metabolome Database HMDB [49]. Dedicated databases
such as the selenoprotein genetics database [8] will be
linked or integrated into the MGP portals.
An online portal has been created at http://www.
micronutrientgenomics.org. This portal allows access to
all information and tools collected and structured by the
Micronutrient Genomics Project. Three basic bioinfor-
matics resources form the backbone of the micronutrient
genomics portal:
1. The nutritional phenotype database
2. The micronutrient pathway portal
3. The micronutrient genetic variation portal
Additional tools are accessible via the main portal or
will be integrated into the three resources mentioned.
Newly emerging tools and data resources will be continu-
ously added, maintaining the micronutrient genomics por-
tal as the central point of access for this type of research.
An important activity of the MGP will also be to contin-
ually critically review the information in these portals and
databases for accuracy and relevance as they evolve and
become more complex.
The nutritional phenotype database
The nutritional phenotype database (dbNP) is a infra-
structural project which allows storage, processing, and
meaningful queries of information on (micro)nutrient-ori-
ented human and animal model intervention studies with
all omics components included (genetics, transcriptomics,
proteomics, metabolomics, biomarkers a.o.), together with
a detailed description of the study design. This resource is
described in a separate paper [45]. The dbNP also allows
additional analyses of existing samples from nutritional
intervention studies and encourages the future collection
and analysis of samples for this purpose.
dbNP is complementing the existing publically available
databases. The data in these valuable resources come from
unconnected studies and populations. dbNP facilitates
comparison of data from harmonized studies where proper
reporting standards are used and metadata describing the
experimental design are captured. Thus, in addition to its
function to utilize existing data from publically available
databases, MGP supports a data repository for ongoing and
new studies of micronutrient–genome interactions. Stan-
dards for incorporating new data and results are being
developed as more complete datasets are obtained from
members of the MGP team.
The development of dbNP is performed as an open-
source modular project (see http://www.dbnp.org), with
clearly described data formats, data communication
standards, and software plugin interfaces. This allows
collaboration with other initiatives to build the necessary
modules of systems biology databases which is already
taking off. It also allows the dbNP analysis tools to work on
external data using the same kind of webservices approa-
ches that are used internally or alternatively to offer data
from dbNP for analysis in other pipelines in an automated
way.
The micronutrient pathway portal
The micronutrient pathway portal is implemented at
http://micronutrients.wikipathways.org and offers all the
functionality available in Wikipathways [40] including a
search option for pathways, genes and metabolites, a
pathway editor, download options in formats relevant for a
number of tools and webservices for programmatic access
[23]. The portal presents micronutrient-related pathways
and biological networks (Fig. 1). For many micronutrients,
knowledge of their biological functions is still fragmented.
Thus, the portal is both a permanent interface for estab-
lished pathways and biological networks, and a ﬂexible
wiki-editable interface for the parts that are being newly
developed. Although the wiki tool allows access to anyone
who registers, professional help and curation is offered by a
core pathway team that also actively constructs and
maintains pathways and biological networks.
The phenotypic expression of the gene–micronutrient
interaction is visualized at the level of transcripts, proteins
and metabolites. Pathways or biological networks are best
shown in a graphical manner. This allows an integrated
view on related parameters and visualization of experi-
mental data. The micronutrient pathway portal features
pathways that combine gene product (transcriptome and
proteome) and metabolome entities (Fig. 1).
The selenium biological network (http://www.wikipath
ways.org/index.php/Pathway:WP15) is presented as an
example (Fig. 1). The relationships in this biological net-
work include molecular interactions, but also established
relationships where the molecular basis is yet not fully
understood. In the selenium network for instance, ‘negative
effects’ are indicated as dotted lines. The visualization also
includes regulation, compartmentalization, and organ
speciﬁcity. An important feature is the visualization of the
288 Genes Nutr (2010) 5:285–296
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components (including transport information). This allows
for analysing and quantifying intracellular micronutrient
mechanisms from a plasma-oriented perspective. This is
essential for human applications where plasma is the prime
source of biomaterial for biomarker analysis. Moreover,
Fig. 1 Example of a WikiPathways visualization of micronutrient biological activity. The selenium pathway provided in Fig. 1a can be found at
http://www.wikipathways.org/index.php/Pathway:WP15. All reactions are manually curated, with references available as demonstrated in Fig. 1b
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way and overarching processes (metabolism, oxidation,
inﬂammation) is indicated.
Detailed biological networks are available for selenium
and folate/B12. Biological networks for iron, carotenoids/
vitamin A, and others are under construction. Straightfor-
ward pathways are available for almost all micronutrients.
Using pathways for analysis
While pathway representations alone can already be very
useful to understand the biological process represented, the
most interesting aspect of pathways is that they can be used
in the analysis of actual study data.
Gene expression Transcriptomics, gene expression regu-
lation (e.g. ChIP and DNA methylation), and proteomics
analyses of the mechanisms of action of micronutrients are
increasing [2, 11, 14, 37]. The construction and optimiza-
tion of the needed pathways and related biological net-
works for micronutrients are performed as part of the MGP.
Available tools allow the statistical evaluation and visual-
ization of this type of information directly on the pathways.
Metabolomics Traditionally, plasma biomarkers are used
to quantify micronutrient status. With the advent of meta-
bolomics, the application of the measurement of the
‘‘complete’’ set of metabolites in an integrated evaluation
of biological activity [43], a broader use of plasma bio-
markers is proposed, linking status biomarkers to health
quantiﬁcation [46]. MGP constructs micronutrient centred
pathway-based biological networks. In these pathways,
intracellular mechanisms related to micronutrient activity
are linked to plasma and blood cell membrane concentra-
tions of all relevant metabolites and (in a later stage)
proteins. Relevant information on the incorporated
metabolites is available via the pathway (Fig. 2).
Analysing genetic variation To allow integration of
genetic data into pathway analyses, the genetic variation
data need to be linked to the available genes in the path-
way. As an example, for MTHFR the gene in the pathway
needs to be linked to the 14 alleles discovered by Marini
et al. [31]. Each gene can show variations that may affect
enzyme or protein properties, inﬂuence protein–protein
interactions, alter gene expression, intron splicing, or RNA
stability and may have copy number variants (CNVs) and
small indels. Visualization tools are being developed to
show subsets of these variations on the pathways. Where
available, this type of information will be linked to the
entities in the pathways using data integration options
offered by BridgeDB [44]. Much of the information about
epistatic combinations that lead to differences in phenotype
is currently not available and thus will be made available as
part of the third resource that MGP is offering: the
micronutrient genetic variation portal. This information
will then be linked to the pathways in the same way that we
previously added information about the micronutrients
themselves through links to the Nugowiki (http://www.
nugowiki.org). This allows making information about the
biological functionality available during pathway analysis.
For example, genes known to have CNVs and those with
SNPs known to alter enzymatic properties may be high-
lighted via colour changes in the pathways. Alternatively,
one might highlight coding variants with associated bio-
chemical data or indicate that transcription factor bindings
are expected to be inﬂuenced by motif variations.
The micronutrient genetic variation portal
The MGP aims at identifying all relevant genetic varia-
tions related to the biological activity of micronutrients
and to make those available for usage in micronutrient
genomics research. While the US National Center for
Biotechnology Information (http://www.ncbi.nlm.nih.gov/)
catalogues sequence variants of all human genes and two
new databases store CNV data (http://projects.tcag.ca/
variation and http://cnv.chop.edu), these genetic variations
are typically still unlinked to phenotypes or to nutritional
effects. The MGP portal will not duplicate the many
resources available for genes, variants, or genomes, but
will rather provide the ability to extract speciﬁc informa-
tion from these resources for interpreting data or devel-
oping experimental strategies. Molecular data are typically
gene centric in these databases, that is, each gene has its
own page of information. SNP data are summarized for a
gene although each SNP has a separate page of informa-
tion, including allele frequencies. Genome browsers are
designed to show the gene in the context of its chromo-
somal location. While each of these ‘‘views’’ is of value,
integrating information for a set of genes or pathways is
time consuming and error prone. In addition, none of the
publically available datasets provides information associ-
ating a gene or variant with a nutrient or phenotype. The
standards and database models for linking genetic varia-
tion to phenotype are being developed by the HVP [21],
and these will be used by the MGP.
Hence, the MGP portal will create tools to dynamically
create tables of gene, variant, and other genomic data for a
pathway or network of genes involved in micronutrient
metabolism. As an example, ﬁlters and search tools will
allow genes in a pathway to be listed with all coding SNPs
(cSNPs) that are non-synonymous or which map to a
chromosomal position associated with a phenotype such as
obesity or diabetes (e.g. [48]). The resultant data will be
shown in tables with an export function for off-line uses
290 Genes Nutr (2010) 5:285–296
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into statistical packages.
Based on the above the micronutrient genetic variation
portal will contain
1. Listsof(linksto)therelevantgenes(whichwillpreferably
partofGeneOntology[3])andthepathwaystheyoccurin.
Thesepathwayswillthenbeonthemicronutrientpathway
portal.Literaturereferencesdescribingthegenesandwhy
theyarepartofthepathwayswillbeaddedtothepathways
themselves. Genes, gene-sets, and literature collections
willalsobemadeavailableonthegeneticvariationportal
toassistanalysisforinstancetoallowcorpusextensionin
text-mining exercises.
2. List of relevant genetic variations in those genes
(preferably linking to database produced by the HVP
initiative) plus links to the original publications or
datasets (where possible uploaded in dbNP) that
describe the relevance of these variations for nutri-
tional phenotype. Each of these variations will be
supplemented with links to other relevant sources
about the genetic variation itself (like dbSNP and
Hapmap) and its implications (like SNPedia and
OMIM).
Technical solutions that allow these links, for a large
part based on BridgeDB [44], have already been developed
and tested.
Fig. 2 The pathways on WikiPathways are linked to relevant
information about the entities present. By clicking on an entity (in
this case methionine), the right panel (backpage) appears with
aggregated information and links to external databases. In this way,
the pathways can provide access to information on genetic variation
in dbSNP which will be extended with information from the genetic
variation portal
Genes Nutr (2010) 5:285–296 291
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Genomics Portal
The Micronutrient Genomics Portal provides readily
accessible information on, for example:
• The metabolic pathways and genes that code for the
receptors, transport proteins required for uptake, trans-
port, storage, metabolism and excretion (for example,
the zinc transporters [27]).
• The genes that code for enzymes that use the micro-
nutrient as substrate to convert it into its biologically
active form.
• The genes that code for enzymes that require the
micronutrient as a cofactor and whose activity is
therefore modiﬁable by the micronutrient concentration
(as example, the zinc-binding proteins involved in
immune function [15]).
• The genes that code for enzymes that require the
micronutrient as an integral part of their structure (e.g.
seleno-enzymes and zinc ﬁnger proteins) and whose
activity is therefore modiﬁable by the micronutrient
concentration.
• Predictive in silico models of the interactive impact of
micronutrient and genotype (for example, the Nijhout
model of folate metabolism [35]).
• Rare mutations [9] and common single nucleotide
polymorphisms in the genes that affect molecular
regulation (transcription, splicing, and RNA turnover)
involved in uptake, transport, metabolism, and excre-
tion of the micronutrient.
• Rare and common single nucleotide polymorphisms in
the enzyme for which the micronutrient is a cofactor.
• Effectoflife-stageandlife-stylefactorsontheexpression
and activity of the enzymes required for the micronutri-
ent’s uptake and activation, and which require it as a
cofactor, and how this affects requirements.
• Current knowledge on the measureable health effects of
insufﬁciency (i.e., subclinical effects), deﬁciency, and
excessanddeterminationofthe‘‘windowofbeneﬁt’’[22]
ordevelopmentalwindowinearlylifestages[13,20, 33].
• The impact of micronutrients on DNA damage and
gene expression. For example, moderate deﬁciencies or
excesses in micronutrients and their interactive effects
(e.g. folate and riboﬂavin or calcium) can cause as
much DNA damage as signiﬁcant doses of known
carcinogens and can alter the gene expression proﬁle in
tissues [7, 12, 29].
• Integrate knowledge from model systems, such as
transgenic mice and appropriate cell culture systems
(e.g. stem cells), into the human knowledge base.
A special future feature is the creation of a harmonized
research protocol that will generate data for local
populations, but which produce data that can be combined
to study the full range of human micronutrient metabolism.
A central database is essential for creating the ability to
compare results from such studies.
Finally, a database with all published intervention
studies on genetics and micronutrients is being created by
the EU Network of Excellence EURRECA and made
available via the MGP portal.
The central point of access for the MGP is created at
http://www.micronutrientgenomics.org. This website pro-
vides information on all project activities, meetings, mem-
bers, expert groups, and a scientiﬁc networking structure.
The above-mentioned bioinformatics databases, tools,
and resources will facilitate the identiﬁcation of the
mechanism of action for each micronutrient depending on
genotype and environmental factors. These are
• Kinetic modelling of micronutrient bioavailability and
efﬁcacy. Physiologically based pharmacokinetic mod-
els are routinely used for such pharmaceutical (e.g.,
[19]) and nutrient analyses [35, 42].
• Metagenomic analyses in response to changing nutrient
intakes [4, 10].
• Systems biology modelling of speciﬁc parts of the
biological networks.
• Flux modelling using stable isotope methodologies
[10, 36, 39, 50].
• Predictive modelling of micronutrient interactive
effects on genome and epigenome stability.
The MGP operational pipeline
For each micronutrient, a MGP expert group is being
formed. The group then acts according to an established
information pipeline. As illustrated schematically in Fig. 3,
each pipeline starts with acquiring the information needed
to construct the biological network, centred around the
micronutrient pathways, and cataloguing of SNPs in genes
that code for the components of metabolic and regulatory
pathways linked to that particular micronutrient. This ini-
tial information provides the basis for the micronutrient
genetic variation portal. Both efforts are assisted by the
bioinformatics team, which incorporates the obtained
information in the relevant portals. The expert teams con-
tinuously evaluate the available data and information, and
identifying those SNPs that have functional consequences.
An embedded goal is also to generate a standardized
review describing all the evidence linking genes with a
speciﬁc micronutrient’s metabolism, clinical signiﬁcance
and toxicity in ethno-culturally diverse populations. Each
review summarizes existing results on feeding trials and
depletion/repletion studies and evaluates all metabolomics,
transcriptomics, proteomics, and genetics/genomics data
292 Genes Nutr (2010) 5:285–296
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measurement units and sample preparation and analytical
methods will be included so as to better enable compari-
sons between studies. Micronutrient intervention studies
will be encouraged to be entered into the nutritional phe-
notype database. A systematic methodology for assembling
the reviews has been developed to ensure consistent
coverage of available information for each micronutrient.
These reviews will also identify gaps in knowledge.
The MGP organization
The MGP was initiated in May 2008 at the Nutrigenomics
2008 conference (Melbourne, Australia). Subsequent pro-
gress meetings were held during NuGOweek 2008 (the
annual European Nutrigenomics Organisation conference) in
Potsdam, Germany, at a special workshop in February 2009
in Vancouver, Canada, during NuGOweek 2009 in Monte-
catini, Italy, and as a satellite of the HVP conference, May
2010. The presentations and meeting minutes are available at
http://www.micronutrientgenomics.org. Further information
can be obtained from the chair of the MGP advisory com-
mittee via the website mentioned above. MGP is collabo-
rating closely with the EURRECA Network of Excellence
which has parallel goals for making recommendations for
micronutrient intakes for the European populations.
Testing the community effort model
The MGP is primarily based on the contribution of
researchers with an interest in its objectives. As mentioned
above, the chosen method to accomplish this community
effort is to shape micronutrient working teams for each
micronutrient. Our current approach is to focus on one
speciﬁc micronutrient to provide tangible proof-of-concept
and guide the development of the informational architec-
ture and web interface necessary to connect users with the
available and emerging data. To date, the focus has been
the micronutrient selenium, because the many genes,
metabolic pathways, and biological processes involved in
are reasonably well understood, and some of the interac-
tions have been mapped by several groups. A bioinfor-
matician, a WikiPathways building expert, and a web
designer are connected to this team. Again, detailed
information on this pilot project can be found on
http://www.micronutrientgenomics.org. Once the lessons
of this pilot expert team are learned, the MGP will proceed
and shape expert teams and further support for all
micronutrients.
Managing a community effort: setting rules on how to grow
A community project is owned by the community, so any
imposition of ownership impedes its shaping and progress.
Managing the MGP should thus be completely transparent,
democratic, and facilitating. During the ﬁrst year of its
shaping, this has been a ‘‘volunteer-only’’ model, with
decisions made via e-mail consensus and meetings. After
this initial phase, the participants proposed a next level of
management structure consisting of a governing body. This
governing body has an expert advisory group (currently
consisting of 6 members) with a chairperson and supported
Fig. 3 The Micronutrient
Genomics Project operational
pipeline demonstrates how the
workﬂow of expert teams and
bioinformaticians produces the
‘Micronutrient Genomics
Portal’. This Portal provides all
basic ‘omics’ information on
micronutrients and thus
becomes a valuable tool for in
vitro and in vivo research
projects, ultimately leading to
relationships between
(individual) genetic variations,
micronutrients, and optimal
health
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123by a secretariat which assumes responsibility for the
website and communication between members. The gov-
erning body determines the timeframe for the work output.
The codes of conduct on intellectual property, collabora-
tion, and data sharing will be developed at future work-
shops. The composition of the governing body will be
reviewed annually, to be decided during progress meetings,
which will occur at least once annually. Progress meetings
will be organized as satellites of relevant symposia and
conferences (HVP, NuGO, Eurreca and various nutrige-
nomics conferences and workshops). Location and dates
can be found at the MGP website. For the portal to become
a community effort, active participation is vital.
Researchers, experts, and stake holders are encouraged to
enquire about the progress of the work output and when
new micronutrient teams will be needed and assembled (for
contact details, see the MGP website).
Conclusion
The establishment of a systematic, centralized repository of
micronutrient-genomicinformationwillprovidethe research
community and health care practitioners with comprehen-
sive, one-of-a-kind access to current and future advances
in all aspects of micronutrient genomics research. Our goal
is to create an unparalleled, comprehensive understanding
of gene–micronutrient interactions, biomarkers of status,
micronutrient requirements, and upper safety limits for
individuals in ethno-culturally diverse subgroups of popu-
lations. The database will allow for the in-depth exploration
of the relationship between micronutrients and chronic dis-
eases in diverse cohorts. Ultimately, the MGP online portal
seeks to facilitate the kinds of research advances that will
enable informed intake recommendations for speciﬁc
micronutrients for both individuals and subpopulations, in
order to prevent acute illness and chronic disease.
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